ONE Bio Corp. (ONBI)
OTCMKTS
· Delayed Price · Currency is USD
0.0200
+0.0198 (9,900.00%)
At close: Oct 3, 2025
ONE Bio Revenue
ONE Bio had revenue of $13.54M in the quarter ending September 30, 2011, with 0.26% growth. This brings the company's revenue in the last twelve months to $53.91M, up 6.13% year-over-year. In the year 2010, ONE Bio had annual revenue of $52.30M with 136.92% growth.
Revenue (ttm)
53.91M
Revenue Growth
+6.13%
P/S Ratio
0.00
Revenue / Employee
150.58K
Employees
358
Market Cap
167.40K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Mid-Atlantic Home Health Network | 27.00M |
ONE Bio News
- 2 years ago - Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal - Seeking Alpha